The DOI matches its Crossref record; 181 of the 190 references it cites were found in a registry or an index.
Wnt signaling and cancer
Open accessAbstract
The regulation of cell growth and survival can be subverted by a variety of genetic defects that alter transcriptional programs normally responsible for controlling cell number. High throughput analysis of these gene expression patterns should ultimately lead to the identification of minimal expression profiles that will serve as common denominators in assigning a cancer to a given category. In the course of defining the common denominators, though, we should not be too surprised to find that cancers within a single category may nevertheless exhibit seemingly disparate genetic defects. The wnt pathway has already provided an outstanding example of this. We now know of three regulatory genes in this pathway that are mutated in primary human cancers and several others that promote experimental cancers in rodents (Fig. 1). In all of these cases the common denominator is the activation of gene transcription by -catenin. The resulting gene expression profile should provide us with a signature common to those cancers carrying defects in the wnt pathway. In this review, the wnt pathway will be covered from the perspective of cancer, with emphasis placed on molecular defects known to promote neoplastic transformation in humans and in animal models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Constitutive activation of this pathway is also implicated in cancer development in several other organs (140).”
From Adrenal incidentaloma (2020) · cites this paper as [140]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Kořínek, V., Barker, N., Clevers, H. C., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 4,000
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
Identification and characterization of the familial adenomatous polyposis coli gene
Groden, J. L., Thliveris, A. T., Samowitz, W. S., Carlson, M. L., Gelbert, L. M., Albertsen, H., Joslyn, G., Stevens, J., Spirio, L. N., Robertson, M. A., et al. (1991) · Cell · doi:10.1016/0092-8674(81)90021-0 · Cited by 2,794
Identification of FAP Locus Genes from Chromosome 5q21
Kinzler, K. W., Nilbert, M. C., Su, L.-K., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hedge, P., McKechnie, D., et al. (1991) · Science · doi:10.1126/science.1651562 · Cited by 2,331
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,030
Nusse, R., & VARMUS, H. E. (1982) · Cell · doi:10.1016/0092-8674(82)90409-3 · Cited by 1,864
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Research works printed but not linked: 1
- 10.1210/jc.85.1.286 · DOI
Cited by
Sorted by citations
Items 901–1,000 of 1,005
The ins and outs of Wingless signaling
Seto, E., & Bellen, H. J. (2003) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.11.004 · Cited by 89
β-catenin mutations in craniopharyngiomas and pituitary adenomas
Oikonomou, E., Barreto, D. C., Soares, B. S., Marco, L. A. D., Buchfelder, M., & Adams, E. F. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-5232-z · Cited by 88
Zhang, Q., Yang, X., Wu, J., Ye, S., Gong, J., Cheng, W. M., Luo, Z., Yu, J., Liu, Y., Zeng, W., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00515-x · Cited by 91
Wang, C., Li, Z., Fu, M., Bouras, T., & Pestell, R. G. (2004) · Cancer treatment and research · doi:10.1007/1-4020-7847-1_11 · Cited by 88
Should I stay or should I go: β-catenin decides under stress
Hoogeboom, D., & Burgering, B. M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.002 · Cited by 90
Adachi, S., Jigami, T., Yasui, T., 中野, 哲., Ohwada, S., Omori, Y., Sugano, S., Ohkawara, B., Shibuyà, H., Nakamura, T., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2254 · Cited by 88
MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling
Ren, J., Raina, D. B., Chen, W., Li, G., Huang, L. H., & Kufe, D. W. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0204 · Cited by 89
Dakeng, S., Duangmano, S., Jiratchariyakul, W., U‐pratya, Y., Bögler, O., & Patmasiriwat, P. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23326 · Cited by 88
Lane, D. J. R., Mills, T. M., Shafie, N. H., Merlot, A. M., Moussa, R., Kalinowski, D. S., Kovačević, Ž., & Richardson, D. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.005 · Cited by 90
Cheng, X., Wang, Z.-C., Chen, X.-Y., Sun, Y., Kong, Q., Liu, J., & Li, H. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.013 · Cited by 87
Tomita, H., Yamada, Y., Oyama, T., Hata, K., Hirose, Y., Hara, A., Kunisada, T., Sugiyama, Y., Adachi, Y., Linhart, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4025 · Cited by 87
Takahashi, M., Fujita, M., Furukawa, Y., Hamamoto, R., Shimokawa, T., Miwa, N., Ogawa, M., & Nakamura, Y. (2002) · PubMed · Cited by 87
Ghosh, J. C., & Altieri, D. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2624 · Cited by 87
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness
Wang, X., Jung, Y., Jun, S., Lee, S., Wang, W., Schneider, A., Oh, Y. S., Lin, S. H., Park, B.-J., Chen, J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10633 · Cited by 89
“Deregulation of Wnt signalling is associated with various human cancers 42,43 .”
Protein kinase B phosphorylates AHNAK and regulates its subcellular localization
Sussman, J., Stokoe, D., Ossina, N., & Shtivelman, E. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105121 · Cited by 87
Konze, S. A., van Diepen, L., Schröder, A., Olmer, R., Möller, H., Pich, A., Weißmann, R., Kuss, A. W., Zweigerdt, R., & Buettner, F. F. R. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.033423 · Cited by 88
“-catenin if cleaved by calpain or if phosphorylated by glycogen synthase kinase 3 in response to Wnt pathway inhibition (76).”
BackgroundShi, J., Liu, Y., Xu, X., Zhang, W., Yu, T., Jia, J., & Liu, C. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00373-15 · Cited by 86
“is stabilized by mutations in APC or -catenin (12, 13).”
BackgroundMacrocyclic Control in Helix Mimetics
Guarracino, D. A., Riordan, J. A., Barreto, G. M., Oldfield, A. L., Kouba, C. M., & Agrinsoni, D. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00623 · Cited by 89
Henry, J. J., Perry, K. J., Wever, J., Seaver, E. C., & Martindale, M. Q. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.042 · Cited by 87
Genome-wide Analysis of CDX2 Binding in Intestinal Epithelial Cells (Caco-2)
Boyd, M., Hansen, M., Jensen, T. G. K., Perearnau, A., Olsen, A. K., Bram, L. L., Bak, M., Tommerup, N., Olsen, J., & Troelsen, J. T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.089516 · Cited by 86
Nuclear transport of galectin-3 and its therapeutic implications
Funasaka, T., Raz, A., & Nangia‐Makker, P. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.004 · Cited by 87
Suriano, G., Mulholland, D. J., Wever, O. D., Ferreira, P. M. P., Mateus, A. R. S., Bruyneel, E. A., Nelson, C. C., Mareel, M. M. K., Yokota, J., Huntsman, D. D., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206672 · Cited by 86
Reichling, T. D., Goss, K. H., Carson, D. J., Holdcraft, R. W., Ebert, C., Witte, D. P., Aronow, B. J., & Groden, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.166.65.1 · Cited by 86
Rhein Induces Apoptosis and Cell Cycle Arrest in Human Hepatocellular Carcinoma BEL-7402 Cells
Shi, P., Huang, Z., & Chen, G. (2008) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x08006259 · Cited by 86
Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular Biomarkers
Tulalamba, W., & Janvilisri, T. (2012) · International Journal of Cell Biology · doi:10.1155/2012/594681 · Cited by 86
“The axin/GSK-3β/APC complex normally phosphorylates βcatenin, leading to its ubiquitin-mediated proteolytic degradation [15, 16].”
BackgroundWNT/Frizzled signaling in eye development and disease
de Iongh Robb, U. (2006) · Frontiers in bioscience · doi:10.2741/1982 · Cited by 88
Pathway-specific tumor suppression
Staheli, J. P., Kim, K.-H., Payne, S. R., Gurley, K. E., Liggitt, D., Longton, G., & Kemp, C. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00054-5 · Cited by 85
Byun, T., Karimi, M., Marsh, J., Milovanović, T., Lin, F., & Holcombe, R. F. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.018598 · Cited by 87
Zhou, J. X., Taramelli, R., Pedrini, E., Knijnenburg, T., & Huang, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-09307-w · Cited by 85
Wang, X., Goode, E. L., Fredericksen, Z. S., Vierkant, R. A., Pankratz, V. S., Liu‐Mares, W., Rider, D. N., Vachon, C. M., Cerhan, J. R., Olson, J. E., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0134 · Cited by 86
Kim, J., Kim, Y. H., Song, G., Kim, D., Jeong, Y., Liu, K., Chung, Y.-H., & Oh, S. (2014) · Food and Chemical Toxicology · doi:10.1016/j.fct.2014.02.019 · Cited by 86
Zhang, Y., Li, Q., Zhou, D., & Chen, H. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512000876 · Cited by 85
“of nuclearb-catenin, disrupts normal cellular events and leads to carcinogenesis((41)).”
BackgroundStructure-Based Discovery of a Novel Inhibitor Targeting the β-Catenin/Tcf4 Interaction
Wang, T., Han, X., Yan, M., Xu, Y., Duggineni, S., Lin, N., Luo, G., Li, Y. M., Han, X., Huang, Z., et al. (2011) · Biochemistry · doi:10.1021/bi201428h · Cited by 88
Reciprocal Targeting of Hath1 and β-Catenin by Wnt Glycogen Synthase Kinase 3β in Human Colon Cancer
Tsuchiya, K., Nakamura, T., Okamoto, R., Kanai∥, T., & Watanabe, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.031 · Cited by 89
Cha, B., Kim, W., Kim, Y., Hwang, B. N., Park, S. Y., Yoon, J., Park, W. S., Cho, J. W., Bedford, M. T., & Jho, E. (2011) · Oncogene · doi:10.1038/onc.2010.610 · Cited by 85
Landman, N., & Kim, T. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.04.001 · Cited by 85
Nucleo-cytoplasmic Shuttling of Axin, a Negative Regulator of the Wnt-β-Catenin Pathway
Wiechens, N., Heinle, K., Englmeier, L., Schohl, A., & Fagotto, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307253200 · Cited by 84
ILKAP regulates ILK signaling and inhibits anchorage-independent growth
Kumar, A. S., Naruszewicz, I., Wang, P., Leung-Hagesteijn, C., & Hannigan, G. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207473 · Cited by 86
Verras, M., Papandreou, I., Lim, A. L., & Denko, N. C. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00947-08 · Cited by 84
Evidence that the canonical Wnt signalling pathway regulates deer antler regeneration
Mount, J., Muzylak, M., Allen, S., Althnaian, T. A., McGonnell, I. M., & Price, J. S. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20742 · Cited by 84
Hergovich, A., Lisztwan, J. H., Thoma, C. R., Wirbelauer, C., Barry, R. E., & Krek, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00232-06 · Cited by 81
FGF18 in colorectal tumour cells: autocrine and paracrine effects
Sonvilla, G., Allerstorfer, S., Stättner, S., Karner, J., Klimpfinger, M., Fischer, H., Grasl‐Kraupp, B., Holzmann, K., Berger, W., Wrba, F., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm202 · Cited by 84
WNTs in the Ovine Uterus: Potential Regulation of Periimplantation Ovine Conceptus Development
Hayashi, K., Burghardt, R. C., Bazer, F. W., & Spencer, T. E. (2007) · Endocrinology · doi:10.1210/en.2007-0283 · Cited by 84
Kanamori, M., Sandy, P., Marzinotto, S., Benetti, R., Kai, C., Hayashizaki, Y., Schneider, C., & Suzuki, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306324200 · Cited by 84
Rui, H.-L., Fan, E., Zhou, H.-M., Xu, Z., Zhang, Y., & Lin, S.-C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208099200 · Cited by 83
The ubiquitin-like modifier FAT10 in cancer development
Aichem, A., & Groettrup, M. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.001 · Cited by 82
Genotype–phenotype relationships in hepatocellular tumors from mice and man†
Stahl, S., Ittrich, C., Marx‐Stoelting, P., Köhle, C., Altug-Teber, Ö., Rieß, O., von Bonin, M., Jobst, J., Kaiser, S., Buchmann, A., et al. (2005) · Hepatology · doi:10.1002/hep.20768 · Cited by 83
Zhou, C., Liu, S., Zhou, X., Xue, L., Quan, L., Lü, N., Zhang, G., Bai, J., Wang, Y., Liu, Z., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20642 · Cited by 83
The Calpain System Is Involved in the Constitutive Regulation of β-Catenin Signaling Functions
Benetti, R., Copetti, T., Dell’Orso, S., Melloni, E., Brancolini, C., Monte, M., & Schneider, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501810200 · Cited by 83
Mælandsmo, G. M., Holm, R., Nesland, J. M., Fodstad, Ø., & Flørenes, V. A. (2003) · PubMed · Cited by 83
Ross, J. S., Stagliano, N. E., Donovan, M. J., Breitbart, R. E., & Ginsburg, G. S. (2001) · Pathology Patterns Reviews · doi:10.1309/ynck-9r19-5ja3-k2k9 · Cited by 83
How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida, M. Q., & Stratakis, C. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.018 · Cited by 85
Jiang, Y. Q., He, X., & Howe, P. H. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.83 · Cited by 85
“Wnt signalling is critical during various developmental and physiological processes, and is implicated in human disease, including cancer (Polakis, 2000; Clevers, 2006).”
The Crucial Role of Atg5 in Cortical Neurogenesis During Early Brain Development
Lv, X., Jiang, H., Li, B., Liang, Q., Wang, S., Zhao, Q., & Jiao, J. (2014) · Scientific Reports · doi:10.1038/srep06010 · Cited by 86
“We observed that the expression of cyclin D1 and c-Myc, downstream target genes of b - Catenin 29,30 , significantly increased after Atg5 knockdown (Fig.”
Liu, G., Bafico, A., & Aaronson, S. A. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3475-3482.2005 · Cited by 85
Oncogenic aberrations of cullin-dependent ubiquitin ligases
Guardavaccaro, D., & Pagano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207413 · Cited by 84
Nuclear β-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas
Buslei, R., Hölsken, A., Hofmann, B., Kreutzer, J., Siebzehnrübl, F. A., Hans, V., Oppel, F., Buchfelder, M., Fahlbusch, R., & Blümcke, I. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0184-3 · Cited by 82
Wnt/Frizzled Signaling in the Vasculature: New Angiogenic Factors in Sight
Masckauchán, T. N. H., & Kitajewski, J. (2006) · Physiology · doi:10.1152/physiol.00058.2005 · Cited by 82
Su, Y., Simmen, F. A., Xiao, R., & Simmen, R. C. M. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00023.2007 · Cited by 82
The molecular pathogenesis of acute myeloid leukemia
Steffen, B., Müller‐Tidow, C., Schwäble, J., Berdel, W. E., & Serve, H. L. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.10.012 · Cited by 85
Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategies
Sakamoto, K. M. (2002) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(02)00146-4 · Cited by 82
Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice
Li, Y., Podsypanina, K., Liu, X., Crane, A., Tan, L. K., Parsons, R. E., & VARMUS, H. E. (2001) · BMC Molecular Biology · doi:10.1186/1471-2199-2-2 · Cited by 82
Yanaka, Y., Muramatsu, T., Uetake, H., Kozaki, K., & Inazawa, J. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv106 · Cited by 82
Woodgett, J. R. (2003) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008033340153 · Cited by 82
Ishigaki, K., Namba, H., Nakashima, M., Nakayama, T., Mitsutake, N., Hayashi, T., Maeda, S., Ichinose, M., Kanematsu, T., & Yamashita, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8648 · Cited by 81
Mutations of β‐catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis
Park, J. Y., Park, W. S., Nam, S. W., Kim, S. Y., Lee, S. H., Yoo, N. J., Lee, J. Y., & Park, C. K. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0995.x · Cited by 81
Funasaka, T., Hogan, V. A., & Raz, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0488 · Cited by 81
Wnt signaling drives WRM-1/β-catenin asymmetries in early C. elegans embryosPreprint
Nakamura, K., Kim, S. Y., Ishidate, T., Bei, Y., Pang, K. M., Shirayama, M., Trzepacz, C., Brownell, D. R., & Mello, C. C. (2005) · Genes & Development · doi:10.1101/gad.1323705 · Cited by 81
Plant Brassinosteroid Hormones
Asami, T., Nakano, T., & Fujioka, S. (2005) · Vitamins and hormones · doi:10.1016/s0083-6729(05)72014-8 · Cited by 80
TCF1 and β-catenin regulate T cell development and function
Yu, Q., Sharma, A., & Sen, J. M. (2010) · Immunologic Research · doi:10.1007/s12026-009-8137-2 · Cited by 80
Shinohara, A., Yokoyama, Y., Wan, X., Takahashi, Y., Mori, Y., Takami, T., Shimokawa, K., & Tamaya, T. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6298 · Cited by 80
β-Catenin Signaling Is a Critical Event in ErbB2-Mediated Mammary Tumor Progression
Schade, B., Lesurf, R., Sanguin‐Gendreau, V., Bui, T., Deblois, G., O’Toole, S. A., Millar, E. K. A., Zardawi, S. J., López‐Knowles, E., Sutherland, R. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3925 · Cited by 80
“Another critical event in the development of human cancer is the dysregulation or mutational activation of the Wnt/β-catenin signaling axis [5].”
BackgroundOvarian cancer: emerging concept on cancer stem cells
Ponnusamy, M. P., & Batra, S. K. (2008) · Journal of Ovarian Research · doi:10.1186/1757-2215-1-4 · Cited by 80
Horvath, L. G., Henshall, S. M., Kench, J. G., Saunders, D. N., Lee, C. S., Golovsky, D., Brenner, P. C., O’Neill, G., Kooner, R., Stricker, P. D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0707-03 · Cited by 80
A new conditional Apc-mutant mouse model for colorectal cancer
Robanus-Maandag, E. C., Koelink, P. J., Breukel, C., Salvatori, D. C. F., Jagmohan–Changur, S., Bosch, C. A. J., Verspaget, H. W., Devilee, P., Fodde, R., & Smits, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq046 · Cited by 80
Bos, C. L., Diks, S. H., Hardwick, J. C. H., Walburg, K. V., Peppelenbosch, M. P., & Richel, D. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl071 · Cited by 80
Wnt Signaling as a Therapeutic Target for Cancer
Herbst, A., & Kolligs, F. T. (2006) · Humana Press eBooks · doi:10.1385/1-59745-208-4:63 · Cited by 82
Adenomatous polyposis coli proteins and cell adhesion
Bienz, M., & Hamada, F. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.08.001 · Cited by 81
The adenomatous polyposis coli protein: in the limelight out at the edge
Dikovskaya, D., Zumbrunn, J., Penman, G. A., & Näthke, I. S. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02069-4 · Cited by 80
Repression of β-catenin signaling by PPARγ ligands
Lu, D., & Carson, D. A. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.010 · Cited by 82
Rohde, F., Rimkus, C., Friederichs, J., Rosenberg, R., Marthen, C., Doll, D., Holzmann, B., Siewert, J., & Janssen, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22868 · Cited by 79
Brachtel, E. F., Sánchez‐Estévez, C., Moreno‐Bueno, G., Prat, J., Palacios, J., & Oliva, E. (2005) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000171001.87599.e2 · Cited by 79
Klotho: a novel biomarker for cancer
Zhou, X., & Wang, X. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1788-y · Cited by 78
“Wnt signaling could cause cancer in prompt tumor progression through various genetic defects, such as mutations of β-catenin, APC, PP2A, and transcription factors (Polakis 2000).”
BackgroundA New β-Catenin-dependent Activation Domain in T Cell Factor
Atcha, F. A., Munguia, J. E., Li, T. W. H., Hovanes, K., & Waterman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213218200 · Cited by 79
McCartney, B. M., Price, M. H., Webb, R. L., Hayden, M. A., Holot, L. M., Zhou, M.-N., Bejsovec, A., & Peifer, M. A. (2006) · Development · doi:10.1242/dev.02398 · Cited by 83
Epithelial Stem Cells and Their Niche: There's No Place Like Home
Rizvi, A. Z., & Wong, M. H. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0096 · Cited by 79
Developmental functions of the P120-catenin sub-family
McCrea, P. D., & Park, J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.06.009 · Cited by 84
Effects of Fertility on Gene Expression and Function of the Bovine Endometrium
Minten, M. A., Bilby, T. R., Bruno, R. G. S., Allen, C. C., Madsen, C. A., Wang, Z., Sawyer, J. E., Tibary, A., Neibergs, H. L., Geary, T. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069444 · Cited by 79
“In humans and mice, the WNT family of genes encodes a group of 19 highly conserved secreted signaling molecules that are critical regulators of cell fate, growth, and differentiation, as well as cell-cell interactions [80].”
BackgroundThe LDL receptor gene family: signaling functions during development
Howell, B. W., & Herz, J. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00176-8 · Cited by 78
Khurana, N., & Sikka, S. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092066 · Cited by 81
“When extracellular Wnt signals are not present, cytoplasmic β-catenin gets phosphorylated by glycogen synthase kinase 3 (GSK3) as part of a destruction axin complex which includes casein kinase 1 (CK1), the tumor suppressor adenomatous polyposis coli gene product (APC) and scaffolding axin proteins [38,39] (Figure 1).”
BackgroundTargeting Wnt Signaling in Endometrial Cancer
Fatima, I., Barman, S., Rai, R., Thiel, K. W., & Chandra, V. (2021) · Cancers · doi:10.3390/cancers13102351 · Cited by 78
“Continuous activation of Wnt signaling can be accomplished through either mutational or non-mutational alterations [12].”
BackgroundImpact of Quercetin and EGCG on Key Elements of the Wnt Pathway in Human Colon Carcinoma Cells
Pahlke, G., Ngiewih, Y., Kern, M., Jakobs, S., Marko, D., & Eisenbrand, G. (2006) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0612530 · Cited by 77
Wang, Y., Zhou, X., Zhu, H., Liu, S., Zhou, C., Zhang, G., Xue, L., Lü, N., Quan, L., Bai, J., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208819 · Cited by 79
Functional Significance of Wnt Inhibitory Factor-1 Gene in Kidney Cancer
Kawakami, K., Hirata, H., Yamamura, S., Kikuno, N., Saini, S., Majid, S., Tanaka, Y., Kawamoto, K., Enokida, H., Nakagawa, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2534 · Cited by 78
A Drosophila APC tumour suppressor homologue functions in cellular adhesion
Hamada, F., & Bienz, M. (2002) · Nature Cell Biology · doi:10.1038/ncb755 · Cited by 84
APC inhibits ERK pathway activation and cellular proliferation induced by RAS
Park, K., Jeon, S. H., Kim, S., Bahk, Y.-Y., Holmen, S. L., Williams, B. O., Chung, K. C., Surh, Y., & Choi, K. (2006) · Journal of Cell Science · doi:10.1242/jcs.02779 · Cited by 78
Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway
Pérez‐Plasencia, C., Dueñas‐González, A., & Alatorre, B. (2008) · International Archives of Medicine · doi:10.1186/1755-7682-1-10 · Cited by 78
Tsai, I.-C., Amack, J. D., Gao, Z.-H., Band, V., Yost, H. J., & Virshup, D. M. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.02.009 · Cited by 67
Metadata
- Authors
- Polakis, P.
- Affiliations
- Genentech (US)
- Corresponding author
- Polakis, Paul
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-08-01
- Volume
- 14
- Issue
- 15
- Pages
- 1837-1851
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2239090104
- Cited by
- 3,183
- References
- 190
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 25 · 2023: 43 · 2022: 39 · 2021: 46 · 2020: 56 · 2019: 67 · 2018: 71 · 2017: 86 · 2016: 110 · 2015: 144 · 2014: 138 · 2013: 147 · 2012: 174
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- Wnt signaling, β-catenin, cancer, oncogenic transformation, transcriptional activation, gene expression profiles, experimental tumor model
- MeSH terms
- Dishevelled Proteins, Animals, Cytoskeletal Proteins, Humans, Neoplasms, Phosphoprotein Phosphatases, Phosphoproteins, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Trans-Activators, Calcium-Calmodulin-Dependent Protein Kinases, Adenomatous Polyposis Coli Protein, Zebrafish Proteins, Glycogen Synthase Kinase 3, Adaptor Proteins, Signal Transducing, Wnt Proteins, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review